SCHEMBL26535952

SCHEMBL26535952

c1cc(-c2ccc(-c3ccc4c5ccccc5c5ccccc5c4c3)cc2)cc(-c2nc3ccccc3o2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.54
ALDH1A1 P00352 8/20 0.54
NPC1 O15118 7/20 0.54
HPGD P15428 7/20 0.54
SMN1; SMN2 Q16637 6/20 0.54
HSD17B10 Q99714 6/20 0.54
MAPT P10636 6/20 0.54
RAB9A P51151 5/20 0.54
USP2 O75604 3/20 0.54
HCRTR1 O43613 2/20 0.54
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
CASP3 P42574 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ATM Q13315 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26535954 1.00 KDM4E (0.54) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL17231514 0.98 KDM4E (0.56) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL26535783 0.98 KDM4E (0.56) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL26535788 0.98 KDM4E (0.56) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL17231525 0.98 KDM4E (0.56) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL26535792 0.97 KDM4E (0.52) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL26535793 0.97 KDM4E (0.52) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL26535955 0.97 KDM4E (0.52) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL17231492 0.95 NPC1 (0.56) KDM4EALDH1A1NPC1HPGDSMN1; SMN2
SCHEMBL17231515 0.92 NPC1 (0.61) KDM4EALDH1A1NPC1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 US disclosed
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CCNT1, CCNE2, SCO2 KDM4E 3380/4885ALDH1A1 240/4885NPC1 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.